Expression of CXCR3 on tumour-infiltrating CD8+ T effector cells also potentiates immune checkpoint inhibition by anti-programmed cell death-1 (PD-L1) in a colorectal cancer model [8]. This evidence concerns the gene CXCR3 and neoplasm.